US 12,337,028 B2
Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof
Weijun Shen, San Diego, CA (US); Pengyu Yang, San Diego, CA (US); Huafei Zou, San Diego, CA (US); and Peter G. Schultz, Carlsbad, CA (US)
Assigned to THE SCRIPPS RESEARCH INSTITUTE, La Jolla, CA (US)
Filed by THE SCRIPPS RESEARCH INSTITUTE, La Jolla, CA (US)
Filed on Nov. 20, 2023, as Appl. No. 18/514,838.
Application 18/514,838 is a division of application No. 17/317,631, filed on May 11, 2021, granted, now 11,865,160.
Application 17/317,631 is a continuation of application No. 16/000,829, filed on Jun. 5, 2018, granted, now 11,007,252, issued on May 18, 2021.
Application 16/000,829 is a continuation of application No. 15/104,807, granted, now 10,039,809, issued on Aug. 7, 2018, previously published as PCT/US2014/070977, filed on Dec. 17, 2014.
Claims priority of provisional application 61/917,816, filed on Dec. 18, 2013.
Prior Publication US 2024/0207363 A1, Jun. 27, 2024
Int. Cl. A61K 38/22 (2006.01); A61K 9/00 (2006.01); A61K 31/20 (2006.01); A61K 38/26 (2006.01); A61K 38/48 (2006.01); A61K 45/06 (2006.01); A61K 47/30 (2006.01); A61K 47/54 (2017.01); A61K 47/60 (2017.01); A61K 9/70 (2006.01)
CPC A61K 38/22 (2013.01) [A61K 9/0019 (2013.01); A61K 9/0021 (2013.01); A61K 38/2278 (2013.01); A61K 38/26 (2013.01); A61K 45/06 (2013.01); A61K 47/54 (2017.08); A61K 47/542 (2017.08); A61K 47/543 (2017.08); A61K 47/554 (2017.08); A61K 47/60 (2017.08); A61K 9/703 (2013.01)] 9 Claims
 
1. A method for treating obesity in a human subject in need thereof, the method comprising administering to the human subject a composition comprising a peptide selected from SEQ ID NOs: 30-32.